64842-0120 LYTGOBI - CanMED: NDC

Product NDC:

64842-0120

Brand Name:

LYTGOBI

Generic Name:

FUTIBATINIB

Dosage Form Name:

TABLET

Administration Route:

Oral

Substances:

Name: FUTIBATINIB

Strength: 4.0

Unit: mg/1

Packages:

Code: 64842-0120-04

Description: 1 BLISTER PACK in 1 CARTON (64842-0120-4) / 21 TABLET in 1 BLISTER PACK

Effective Date: Feb. 3, 2023

Discontinued:

Code: 64842-0120-05

Description: 1 BLISTER PACK in 1 CARTON (64842-0120-5) / 28 TABLET in 1 BLISTER PACK

Effective Date: Feb. 3, 2023

Discontinued:

Code: 64842-0120-06

Description: 1 BLISTER PACK in 1 CARTON (64842-0120-6) / 35 TABLET in 1 BLISTER PACK

Effective Date: Feb. 3, 2023

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

FGFR

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox